Potassium Cl 2meq/ml Inj 250ml
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
Lifestyle & Tips
- For patients receiving IV potassium, dietary changes are usually not the primary treatment. However, once stable, your doctor may recommend increasing potassium-rich foods (e.g., bananas, oranges, potatoes, leafy greens) to help maintain levels.
- Avoid excessive alcohol intake, which can contribute to electrolyte imbalances.
- Report any new medications or supplements to your healthcare provider, especially those that can affect potassium levels (e.g., certain blood pressure medications, diuretics).
Available Forms & Alternatives
Available Strengths:
- Potassium Cl 2meq/ml Inj 30ml
- Kcl/d5w/nacl 0.15/0.9 Inj , 1000ml
- Kcl/d5w/nacl .15/.45% Inj, 1000ml
- Potassium Cl 2meq/ml Inj 20ml
- Potassium Cl 2meq/ml Inj 10ml
- Potassium Cl 2meq/ml Inj 20ml
- Pot Chl/nacl 0.15/.45% Inj, 1000ml
- Kcl/d5w/lr 0.15% Inj, 1000ml
- Pot Chloride 20meq Inj, 100ml
- Kcl/d5w/nacl 0.3/0.45 Inj, 1000ml
- Kcl/d5w/nacl .075/.45 Inj, 1000ml
- Kcl/d5w/nacl 0.15/0.2 Inj, 1000ml
- Pot Chl/dextrose 5%/nacl0.45% Inj
- Potassium Chloride ER 8meq Tablets
- Potassium Cl 10meq ER Tablets
- Potassium Chloride ER 8meq ER Tabs
- Potassium Cl 10meq ER Capsules
- Potassium Chlor 10% Liq(20meq/15ml)
- Potassium Chlor 20% Liq(40meq/15ml)
- Potassium Cl Micro 10meq ER Tabs
- Pot Chloride 8meq CR Capsules
- Potassium Chloride 20meq Powder Pkt
- Potassium Cl Micro 10meq ER Tabs
- Potassium Cit ER 1620mg (15meq) Tab
- Potassium Cl Micro 10meq ER Tabs
- Potassium Chl 40meq Inj, 100ml
- Potassium Chloride 10meq Inj, 50ml
- Potassium Chloride 20meq Inj, 50ml
- Potassium Chloride 10meq ER Tablets
- Kcl/d5w/lact 20meq/l Inj, 1000ml
- Potassium Chloride 20meq ER Tablets
- Potassium Cl 20meq ER Tablets
- Potassium Chloride 20meqpowder Pkt
- Potassium Cl 2meq/ml Inj 250ml
- Potassium Cl 2meq/ml Inj 50ml
- Potassium Chl 10meq Inj,100ml
- Pot Chl/nacl 40meq/l Inj, 1000ml
- Pot Chl/d5w 20meq/l Inj, 1000ml
- Pot Chl/d5w 10meq/l Inj, 1000ml
- Potassium Chlor/nacl 20meq/l Inj
- Potassium Chloride 15meq ER Tabs
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high potassium levels, including:
+ Abnormal heartbeat
+ Confusion
+ Weakness
+ Lightheadedness or dizziness
+ Feeling like passing out
+ Numbness or tingling
+ Shortness of breath
Slow heartbeat
Chest pain or pressure
Signs of low sodium levels, such as:
+ Headache
+ Difficulty focusing
+ Memory problems
+ Confusion
+ Weakness
+ Seizures
+ Changes in balance
Shortness of breath, significant weight gain, or swelling in the arms or legs
* Tissue damage at the injection site, characterized by:
+ Redness
+ Burning
+ Pain
+ Swelling
+ Blisters
+ Skin sores
+ Leaking of fluid
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you have any side effects that bother you or persist, contact your doctor for guidance.
Reporting Side Effects
If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Symptoms of too much potassium (hyperkalemia): unusual tiredness, weakness, numbness or tingling, slow or irregular heartbeat, nausea, vomiting, diarrhea, abdominal pain.
- Symptoms of too little potassium (hypokalemia) returning: muscle weakness, cramps, fatigue, constipation, irregular heartbeat.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
If you have high potassium levels, as this may affect the safety of taking this medication.
If you are currently taking any of the following medications: Amiloride, Eplerenone, Spironolactone, or Triamterene, as these may interact with this drug.
Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to:
Inform your doctor and pharmacist about all the medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins.
Discuss all your health problems with your doctor to determine if it is safe for you to take this medication.
Never start, stop, or change the dose of any medication without first consulting your doctor to avoid potential interactions or adverse effects.
Precautions & Cautions
To minimize the risk of severe side effects, it is crucial to adhere to the prescribed dosage and not exceed the amount recommended by your doctor. If you follow a low-salt diet or use a salt substitute, consult with your doctor to discuss any potential interactions.
Certain formulations of this medication may not be suitable for children, so it is essential to consult with your doctor if you have any questions or concerns. Additionally, if you are pregnant, planning to become pregnant, or breastfeeding, you should discuss the potential benefits and risks of this medication with your doctor to make an informed decision about your treatment.
Overdose Information
Overdose Symptoms:
- Hyperkalemia (serum K+ > 5.0 mEq/L)
- Cardiac arrhythmias (peaked T waves, widened QRS, ventricular fibrillation, asystole)
- Muscle weakness, flaccid paralysis
- Paresthesias
- Confusion
- Hypotension
What to Do:
Immediate discontinuation of potassium infusion. Administration of calcium gluconate (to stabilize cardiac membrane), insulin and glucose (to shift potassium intracellularly), sodium bicarbonate (for acidosis), loop diuretics (if renal function adequate), or emergent hemodialysis for severe, refractory hyperkalemia. Continuous ECG monitoring is essential. Call 1-800-222-1222 (Poison Control).
Drug Interactions
Contraindicated Interactions
- Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene) in patients with hyperkalemia or significant renal impairment
- Patients with hyperkalemia (serum potassium > 5.0 mEq/L)
- Severe renal impairment (anuria, oliguria) unless on dialysis
- Addison's disease (untreated)
- Acute dehydration
- Extensive tissue breakdown (e.g., severe burns, rhabdomyolysis) where hyperkalemia is a risk
Major Interactions
- ACE inhibitors (e.g., lisinopril, enalapril): Increased risk of hyperkalemia
- Angiotensin Receptor Blockers (ARBs) (e.g., valsartan, losartan): Increased risk of hyperkalemia
- NSAIDs (e.g., ibuprofen, naproxen): May impair renal potassium excretion, increasing hyperkalemia risk
- Cyclosporine, Tacrolimus: May increase serum potassium levels
- Heparin: Can cause hypoaldosteronism, leading to hyperkalemia
- Beta-blockers (non-selective): May impair cellular potassium uptake, increasing serum potassium
Moderate Interactions
- Digoxin: Hypokalemia potentiates digoxin toxicity; hyperkalemia can reduce digoxin efficacy.
- Insulin: Drives potassium into cells, potentially causing transient hypokalemia (relevant during DKA treatment).
- Corticosteroids: May increase renal potassium excretion, potentially requiring higher potassium doses.
Minor Interactions
- Laxatives (chronic use): May increase potassium loss from GI tract.
Monitoring
Baseline Monitoring
Rationale: To determine the degree of hypokalemia and guide initial dosing.
Timing: Prior to initiation of therapy.
Rationale: Potassium is primarily renally excreted; impaired renal function increases risk of hyperkalemia.
Timing: Prior to initiation of therapy.
Rationale: To assess for cardiac manifestations of hypokalemia (e.g., U waves, flattened T waves, ST depression) and establish baseline cardiac rhythm.
Timing: Prior to initiation, especially in severe hypokalemia.
Rationale: Hypomagnesemia can impair potassium repletion; other electrolyte imbalances may coexist.
Timing: Prior to initiation.
Routine Monitoring
Frequency: Every 2-4 hours during active repletion for severe hypokalemia; every 6-12 hours for moderate; daily for maintenance.
Target: 3.5-5.0 mEq/L
Action Threshold: If K+ > 5.0 mEq/L, stop infusion and assess for hyperkalemia. If K+ < 3.0 mEq/L, consider increasing infusion rate (within safe limits) or adding oral supplementation.
Frequency: Continuous monitoring during rapid infusion or severe hypokalemia; intermittent monitoring otherwise.
Target: Normal sinus rhythm, absence of hyperkalemia/hypokalemia changes.
Action Threshold: Development of peaked T waves, widened QRS, PR prolongation (hyperkalemia) or U waves, flattened T waves, ST depression (hypokalemia) requires immediate intervention.
Frequency: Daily or as clinically indicated, especially in patients with pre-existing renal impairment.
Target: Stable or improving
Action Threshold: Significant worsening of renal function requires re-evaluation of potassium dosing.
Frequency: Every 4-8 hours
Target: Appropriate for patient's condition
Action Threshold: Significant fluid overload or dehydration requires adjustment of IV fluids.
Frequency: Every 1-4 hours during infusion
Target: Within normal limits for patient
Action Threshold: Significant changes may indicate cardiac effects of potassium imbalance.
Symptom Monitoring
- Muscle weakness
- Fatigue
- Muscle cramps
- Paresthesias (tingling, numbness)
- Palpitations or irregular heartbeat
- Nausea, vomiting, abdominal distension
- Decreased bowel sounds (ileus)
- Confusion or altered mental status
Special Patient Groups
Pregnancy
Potassium is an essential electrolyte. Replacement therapy is indicated when hypokalemia occurs during pregnancy. Use with caution and monitor serum levels closely. Category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Trimester-Specific Risks:
Lactation
Potassium is a normal component of breast milk. Excretion into breast milk is expected but unlikely to cause adverse effects in a healthy, full-term infant when administered to the mother in therapeutic doses. Monitor infant for signs of electrolyte imbalance if mother receives high doses.
Pediatric Use
Dosing must be carefully calculated based on weight, age, and severity of hypokalemia. Infusion rates and concentrations must be strictly adhered to, as children are more susceptible to the adverse effects of hyperkalemia. Continuous ECG monitoring is often recommended for moderate to severe hypokalemia.
Geriatric Use
Elderly patients are at increased risk for renal impairment, which can lead to decreased potassium excretion and an increased risk of hyperkalemia. They may also be on medications that affect potassium levels (e.g., ACE inhibitors, diuretics). Close monitoring of renal function and serum potassium is essential. Start with lower doses and titrate carefully.
Clinical Information
Clinical Pearls
- NEVER administer concentrated potassium chloride (e.g., 2 mEq/mL) undiluted or as an IV push. This is a lethal dose and can cause immediate cardiac arrest.
- Always dilute potassium chloride concentrate in a large volume of IV fluid (e.g., D5W, NS) before administration.
- Maximum recommended peripheral infusion concentration is typically 40 mEq/L. Higher concentrations (up to 60-80 mEq/L) may be used via central venous access with continuous cardiac monitoring.
- Maximum infusion rate should generally not exceed 10-20 mEq/hour in adults, except in life-threatening situations with continuous ECG monitoring and close supervision.
- Rapid infusion can cause local pain and phlebitis at the injection site. Use a large vein and ensure proper dilution.
- Always correct hypomagnesemia before or concurrently with potassium repletion, as magnesium is required for cellular potassium uptake.
- Monitor serum potassium, renal function, and ECG frequently during potassium replacement therapy.
- Patients with renal impairment are at significantly higher risk of hyperkalemia; dose adjustments are crucial.
- Be aware of drug interactions that can increase serum potassium (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics, NSAIDs).
Alternative Therapies
- Oral potassium supplements (e.g., potassium chloride tablets, liquid solutions) for mild to moderate hypokalemia or maintenance.
- Dietary modifications (increasing intake of potassium-rich foods like fruits, vegetables, and certain dairy products) for mild hypokalemia or prevention.